SEVELAMER HYDROCHLORIDE

SEVELAMER HYDROCHLORIDE
(se-vel'a-mer)
Renagel
Classifications: electrolyte and water balance agent; phosphate binder;
Therapeutic: phosphate binder

Pregnancy Category: C

Availability

403 mg capsules; 400 mg, 800 mg tablets

Action

Polymer that binds intestinal phosphate; interacts with phosphate by way of ion-exchange and hydrogen binding. Advantageously, does not contain aluminum or calcium in treating hyperphosphatemia in end stage kidney failure.

Therapeutic Effect

Indicated by a serum phosphate level ≤6.0 mg/dL.

Uses

Reduction of serum phosphorus in patients with end-stage kidney disease.

Contraindications

Hypophosphatemia; hypersensitivity to sevelamer HCl; fecal impaction; bowel obstruction; hypophosphatemia; appendicitis; dysphagia, GI bleeding, major GI surgery; pregnancy (category C), lactation. Safety and efficacy in children <18 y are not established.

Cautious Use

GI motility disorders; vitamin deficiencies (especially vitamins D, E, and K and folic acid).

Route & Dosage

Hyperphosphatemia
Adult: PO 2 capsules or tablets t.i.d. for serum phosphorus >6 and <7.5 mg/dL; 3 capsules or tablets t.i.d. for serum phosphorus >7.5 and <9 mg/dL; 4 capsules or tablets t.i.d. for serum phosphorus ≥9 mg/dL

Administration

Oral
  • Give with meals; do not open or chew capsule.
  • Give other oral medications 1 h before or 3 h after Renagel.
  • Discard capsules after printed expiration date.
  • Store at 15°–30° C (59°–86° F); protect from moisture.

Adverse Effects (≥1%)

Body as a Whole: Headache, infection, pain. CV: Hypertension, hypotension, thrombosis. GI: Diarrhea, dyspepsia, vomiting, nausea, constipation, flatulence. Respiratory: Increased cough.

Nursing Implications

Assessment & Drug Effects

  • Lab tests: Obtain frequent serum phosphate levels.

Patient & Family Education

  • Do not use capsules after printed expiration date.
  • Take daily multivitamin supplement approved by physician.

Common adverse effects in italic, life-threatening effects underlined; generic names in bold; classifications in SMALL CAPS; Canadian drug name; Prototype drug

(247)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.
© 2006-2025 medpill.info Last Updated On: 05/21/2025 (0.01)
×
Wait 20 seconds...!!!